Treatments

Dr

Christopher McNamara

FRACP, FRCPA, FRCPath

Speciality

Haematology

Biography

Dr Christopher McNamara is a consultant haematologist with an interest in general haematology and haematologic malignancies. His specialty interest is in lymphoma and in this subject he has published extensively. He has been involved in the development of treatment guidelines for haematology patients, nationally, for the British Committee for Standardisation in Haematology, and internationally, for the European Society of Medical Oncology. He has worked extensively in the development of new therapies and clinical trials, notably in the field of radio-immunotherapy for Hodgkin lymphoma patients.

He also has a strong interest in providing specialist diagnostic services for haematology patients and is involved in teaching, examinations and quality assurance programs in this field.

HCA Healthcare UK

Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.

£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.

Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.

Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.

Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.